Skip to main content
Clinical Trials/NCT05537012
NCT05537012CompletedNot Applicable

Incidence of Unresectable Cases of Cervical Cancer in Gyne-oncology Unit of Alexandria University Hospital and Its Relation to Pathological Types, Grading and Lymph Vascular Space Invasion

HOSSAM ALSUKARI1 site in 1 country70 target enrollmentStarted: March 1, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
70
Locations
1
Primary Endpoint
clinical and radiological staging

Study Overview

Brief Summary

Objective : to calculate the incidence of unresectable cases of cervical cancer in gyne-oncology unit of Alexandria university hospital and to indentify its relation to pathological types, grading and lymph vascular space invasion.

Patients and methods: 70 cases of cervical cancer diagnosed by biopsy taking and histopathological examination will be included in the study, clinicoradiological staging was done to all cases to calculate the incidence of unresectable cases and to indentify its relation to pathological types, grading and lymph vascular space invasion

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Cross Sectional

Eligibility Criteria

Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • cervical cancer

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

clinical and radiological staging

Time Frame: 10 days

70 cases of cervical cancer diagnosed by biopsy taking and histopathological examination will be included in the study, clinicoradiological staging was done to all cases to calculate the incidence of unresectable cases and to indentify its relation to pathological types, grading and lymph vascular space invasion.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
HOSSAM ALSUKARI
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

HOSSAM ALSUKARI

Associate professor

Alexandria University

Study Sites (1)

Loading locations...

Similar Trials

Incidence of Unresectable Cases of... | Clinical Trial